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Abstract
Introduction: Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a new disease entity characterized by high
serum IgG4 levels, IgG4-positive plasmacytic infiltration, and fibrosis in various organs. The purpose of this study
was to determine the mechanism of upregulation of IgG4 class switch recombination in IgG4-RD.
Methods: We extracted RNA from peripheral blood mononuclear cells (PBMCs) of patients with IgG4-RD (n = 6),
Sjögren syndrome (SS) (n = 6), and healthy controls (n = 8), from CD3-positive T cells and CD20-positive B cells
sorted from PBMCs of patients with IgG4-RD (n = 3), SS (n = 4), and healthy controls (n = 4), as well as from labial
salivary glands (LSGs) of patients with IgG4-RD (n = 11), SS (n = 13), and healthy controls (n = 3). The mRNA
expression levels of IgG4-specific class switch-related molecules, such as Th2 cytokines (IL-4 and IL-13), Treg
cytokines (IL-10 and TGF-b), and transcriptional factors (GATA3 and Foxp3) were examined with quantitative
polymerase chain reaction (PCR). IgG4-nonspecific class switch-related molecules, such as CD40, CD154, BAFF,
APRIL, IRF4, and AID, were also examined.
Results: The expression levels of Treg cytokines (IL-10 and TGF-b) and AID were significantly higher in LSGs of
IgG4-RD than in SS and the controls (P < 0.05, each). In contrast, those of CD40 and CD154 were significantly
lower in PBMCs of IgG4-RD than in SS (P < 0.05, each), whereas CD40 in CD20-positive B cells and CD154 in
CD3-positive T cells were comparable in the three groups.
Conclusion: Overexpression of IL-10, TGF-b, and AID in LSGs might play important roles in the pathogenesis of
IgG4-RD, such as IgG4-specific class-switch recombination and fibrosis. IgG4 class-switch recombination seems to
be mainly upregulated in affected organs.
Introduction
IgG4-related disease (IgG4-RD) is a new disease entity
characterized by high serum IgG4 levels, infiltration of
IgG4-positive plasmacytes, and fibrosis of various
organs, such as pancreas, bile duct, salivary and lacrimal
glands, thyroid, lung, liver, kidney, prostate, aorta, retro-
peritoneum, and lymph nodes [1,2]. Although the clini-
cal features including serum abnormalities, organ
involvement, diagnosis, and the therapeutic approach
have been reported recently [1,2], the pathogenesis of
this disease, including the roles of high IgG4 and IgG4-
positive plasmacytes, and the molecular mechanism
involved in the upregulation of IgG4 class-switch
recombination remains unclear.
Recent studies reported increased proportions of type 2
helper T (Th2) cells and regulatory T (Treg) cells and
increased production levels of Th2 and Treg cytokines in
tissues of IgG4-RD, such as sclerosing pancreatitis and
cholangitis [3], sialadenitis [4,5], and tubulointerstitial
nephritis [6]. Moreover, high Th2 cell count and overpro-
duction of Th2 cytokines have been described in periph-
eral blood of IgG4-RD [4,7], as well as in Treg cells [8].
It is reported that Th2 cytokines (IL-4 and IL-13) and
Treg cytokine (IL-10) can induce IgG4- and IgE-specific
class-switch recombination [9,10], and tumor growth fac-
tor (TGF)-b, a Treg cytokine, could induce tissue fibrosis
[11]. Thus, increased production of IL-4, IL-13, IL-10, and
TGF-b could contribute to the pathogenesis of IgG4-RD,
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including high serum IgG4 level, IgG4-positive plasmacy-
tic infiltration, and fibrosis.
Conversely, CD40, CD154, B-cell activating factor
belonging to the tumor necrosis factor family (BAFF), a
proliferation-inducing ligand (APRIL), interferon regula-
tory factor 4 (IRF4), activation-induced cytidine deaminase
(AID), and IL-21 contribute to nonspecific immunoglobu-
lin class-switch recombination (from IgM to IgG1, IgG2,
IgG3, IgG4, IgA, and IgE) [12-14], as well as IL-4, IL-13,
IL-10, and TGF-b. The roles of these nonspecific immuno-
globulin class switch-related molecules in the pathogenesis
of IgG4-RD have not been reported previously.
To determine the mechanism of upregulation of IgG4
class-switch recombination in IgG4-RD, the mRNA
expression levels of IgG4-specific and nonspecific class
switch-related molecules were first measured in periph-
eral blood mononuclear cells (PBMCs), CD3-positive
T cells, and CD20-positive B cells sorted from PBMCs, as
well as labial salivary glands (LSGs) of IgG4-RD. Then,
these levels were compared with those measured in
patients with Sjögren syndrome (SS) and in healthy
controls.
Materials and methods
Study population
PBMC samples were collected from six Japanese
patients with IgG4-RD, as well as from six Japanese
patients with SS who had been followed up at the Uni-
versity of Tsukuba Hospital (Ibaraki, Japan). LSG sam-
ples were also collected from 11 Japanese patients with
IgG4-RD and 13 Japanese patients with SS who had
been followed up at the University of Tsukuba Hospital
and Kyushu University Hospital (Fukuoka, Japan). All
patients with IgG4-RD satisfied the comprehensive diag-
nostic criteria for IgG4-related disease (IgG4-RD) 2011
proposed by the All Japan IgG4 team [15]. The diagno-
sis of IgG4-RD was based on the presence of all three
items: (1) clinical examination showing characteristic
diffuse/localized swelling or masses in single or multiple
organs, (2) hematologic examination showing elevated
serum IgG4 concentrations (135 mg/dl), and (3) histo-
pathologic examination showing (a) marked lymphocyte
and plasmacyte infiltration and fibrosis; (b) infiltration
of IgG4+ plasma cells: ratio of IgG4+/IgG+ cells >40%
and >10 IgG4+ plasma cells/HPF. All patients with SS
satisfied the Japanese Ministry of Health criteria for the
diagnosis of SS (1999) [16]. These criteria included four
clinicopathologic findings: lymphocytic infiltration of the
salivary or lacrimal glands, dysfunction of salivary secre-
tion, keratoconjunctivitis sicca, and presence of anti-SS-
A or -SS-B antibodies. The diagnosis of SS was based on
the presence of two or more of these four items. We also
collected control samples: PBMCs from eight and LSGs
from three healthy subjects. Approval for this study was
obtained from the local ethics committee, and a signed
informed consent was obtained from each subject.
Sorting of CD3-positive T cells and CD20-positive B cells
from PBMCs with flow cytometry
PBMCs derived from IgG4-RD (n = 3), SS (n = 4), and
controls (n = 4) were stained with anti-CD3 antibody
conjugated with FITC (BioLegend, San Diego, CA, USA)
and anti-CD20 antibody conjugated with APC (BioLe-
gend). Stained PBMCs were analyzed and sorted with
flow cytometry.
Analysis of mRNA expression levels of IgG4-specific and
nonspecific class switch-related molecules in PBMCs and
LSGs
Total RNA was extracted from PBMCs, CD3-positive T
cells, and CD20-positive B cells sorted from PBMCs, as
well as LSGs, by the ISOGEN method, and cDNA was
synthesized by a cDNA synthesis kit (Takara, Otsu, Shiga,
Japan). The mRNA expression levels of IgG4-specific class
switch-related molecules, such as Th2 cytokines (IL-4 and
IL-13), Treg cytokines (IL-10 and TGF-b), and transcrip-
tional factors (GATA3 and Foxp3) were examined with
quantitative PCR. IgG4-nonspecific class switch-related
molecules, such as CD40, CD154, BAFF, APRIL, IRF4, and
AID also were examined. The human glyceralaldehyde-3-
phosphate dehydrogenase (GAPDH) was examined as an
internal control.
Statistical analysis
Differences between groups were examined for statistical
significance by using the Mann-Whitney U test, whereas
differences in frequencies were analyzed with the Fisher
Exact probability test. A P value less than 0.05 denoted
the presence of a statistically significant difference.
Results
Clinical and pathologic features of patients and controls
Table 1 summarizes the clinical and pathologic features
of participating subjects. The frequencies of anti SS-A
antibodies and anti SS-B antibodies were significantly
lower in IgG4-RD than in SS (P < 0.05; Fisher Exact
probability test). CH50 levels were also significantly
lower in IgG4-RD than in SS (P < 0.05, Mann-Whitney U
test). Table 2 shows material sampling and organ involve-
ments in patients with IgG4-RD. All LSG samples used in
this study satisfied histopathologic findings of the com-
prehensive diagnostic criteria for IgG4-related disease
(IgG4-RD) proposed in 2011 by the All Japan IgG4 team
[15]. As shown in Table 2, seven of 15 IgG4-RD patients
showed salivary and lacrimal glands involvement alone,
whereas the others had multiple organ involvements.
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The cell population of CD3-positive T cells and CD20-
positive B cells in PBMCs
Figure 1 shows the cell population of CD3-positive T
cells and CD20-positive B cells sorted from PBMCs of
patients with IgG4-RD (n = 3), SS (n = 4), and the con-
trol (n = 4). The population of CD20-positive B cells in
SS was higher than the others (no statistically significant
difference), whereas that of CD3-positive T cells was
comparable in the three groups.
The mRNA expression levels of IgG4-specific class switch-
related molecules in PBMCs, CD3-positive T cells, and
CD20-positive B cells in PBMCs and LSGs
Figure 2 shows the mRNA expression levels of IgG4-speci-
fic class switch-related molecules in PBMCs and LSGs.
The mRNA expression level of IL-4 was significantly
higher in LSGs of IgG4-RD than in the control (P < 0.05,
Mann-Whitney U test). Treg cytokines (IL-10 and TGF-b)
were significantly higher in LSGs of IgG4-RD than SS and
control (P < 0.05, each, Mann-Whitney U test). No signifi-
cant differences were noted in the PBMC expression levels
of various cytokines, among the three groups. In LSGs, the
expression of GATA3 was significantly lower in IgG4-RD
than in SS; Foxp3 was significantly higher in IgG4-RD and
SS than in the control (P < 0.05; Mann-Whitney U test).
However, no statistically significant difference in Foxp3
expression level was seen between IgG4-RD and SS.
No significant differences were seen in the expression
levels of various IgG4-specific class switch-related mole-
cules in CD3-positive T cells and CD20-positive B cells
Table 1 Clinical and pathologic features of patients and
controls
Parameter IgG4-RD (n = 15) SS (n = 16) HC (n = 10)
Age (years) 62.9 ± 10.5a 55.9 ± 15.7a 40.9 ± 17.1
Sex (males/females) 6/9 2/14 5/5
Anti-SS-A antibody (%) 0b 93.8 n.d.
Anti-SS-B antibody (%) 0b 56.3 n.d.
Serum IgG4 (mg/dl) 942.2 ± 612.5 n.d n.d.
Serum IgE (U/ml) 294.0 ± 317.8 n.d n.d.
CH50 (U/ml) 33.6 ± 17.5b 50.6 ± 16.3 n.d.
IgG4/IgG in LSG (%) 62.0 ± 3.5 n.d n.d.
Data are expressed as mean ± SD. n.d., not determined. aP < 0.05, compared
with the healthy control subjects (Mann-Whitney U test or Fisher Exact
probability test). bP < 0.05, compared with the SS group (Mann-Whitney U test
or Fisher Exact probability test).
Table 2 Material sampling and organ involvements in patients with IgG4-RD
Case Material sampling Organ involvement
PBMC CD3/CD20 LSGa
1 ○ ○ MD, lymph node, lung
2 ○ ○ MD, lymph node
3 ○ ○ MD
4 ○ MD, lymph node
5 ○ MD, lung
6 ○ ○ MD, lymph node, para-aorta swelling
7 ○ ○ Intraorbital mass, retroperitoneal fibrosis
8 ○ MD
9 ○ MD
10 ○ MD
11 ○ MD
12 ○ MD
13 ○ MD
14 ○ MD, lung
15 ○ MD, liver
PBMCs, peripheral blood mononuclear cells; CD3/CD20, CD3-positive T cells and CD20-positive B cells sorted from PBMCs; LSG, labial salivary gland; MD, Mikulicz
disease (salivary and lacrimal glands). aAll LSG samples satisfied histopathologic findings of the comprehensive diagnostic criteria for IgG4-related disease (IgG4-
RD) 2011.
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Figure 1 The cell population of CD3-positive T cells and CD20-
positive B cells in peripheral blood mononuclear cells. PBMCs
stained with anti-CD3 antibody and anti-CD20 antibody were
analyzed and sorted with flow cytometory. HC, healthy control; SS,
Sjögren syndrome; IgG4, IgG4-RD.
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sorted from PBMCs, among the three groups (data not
shown).
The mRNA expression levels of IgG4-nonspecific class
switch-related molecules in PBMCs, CD3-positive T cells,
and CD20-positive B cells in PBMCs and LSGs
Figure 3 displays the mRNA expression levels of IgG4-
nonspecific class switch-related molecules in PBMCs and
LSGs. The mRNA expression levels of CD40 and CD154
were significantly lower in PBMCs of IgG4-RD than in
SS (P < 0.05, each; Mann-Whitney U test). The expres-
sion of BAFF was significantly higher in LSGs of IgG4-
RD than in the control (P < 0.05; Mann-Whitney U test).
The expression of APRIL was significantly lower in
PBMCs of IgG4-RD than in the control (P < 0.05; Mann-
Whitney U test). The expression of AID was significantly
higher in LSGs of IgG4-RD than in SS and the control
(P < 0.05, each; Mann-Whitney U test).
Figure 4 shows the mRNA expression levels of IgG4-
nonspecific class switch-related molecules in CD3-posi-
tive T cells and CD20-positive B cells sorted from
PBMCs. In contrast to PBMCs, the expressions of CD40
in CD20-positive B cells and that of CD154 in CD3-
positive T cells were comparable in the three groups.
Moreover, no significant difference occurred in the
expression of APRIL in CD3-positive T cells and CD20-
positive B cells sorted from PBMCs, among the three
groups. The expression of AID in CD20-positive B cells
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Figure 2 The mRNA expression levels of IgG4-specific class switch-related molecules in PBMCs and LSGs. The displayed mRNA
expression levels are relative to the mRNA level of GAPDH, representing the internal control. Data are expressed as mean ± SD. *P < 0.05, Mann-
Whitney U test. PBMCs, peripheral blood mononuclear cells; LSGs, labial salivary glands; HC, healthy control; SS, Sjögren syndrome; IgG4, IgG4-RD.
Tsuboi et al. Arthritis Research & Therapy 2012, 14:R171
http://arthritis-research.com/content/14/4/R171
Page 4 of 7
from IgG4-RD was higher than others (no statistically
significant difference).
Discussion
The clinical and pathologic features of patients with
IgG4-RD participating in this study (such as low fre-
quencies of anti SS-A antibodies and anti SS-B antibo-
dies, high serum IgG4 levels, high IgG4/IgG in LSGs,
and low CH50 levels) accord with previous reports [1].
We revealed the mRNA expression levels of IgG4-spe-
cific and nonspecific class switch-related molecules in
both PBMCs and LSGs of IgG4-RD, and then, these
levels were compared with those measured in patients
with SS and controls. We focused on the molecules
with different expression levels in IgG4-RD than in SS
and control, with the assumption that these molecules
could be IgG4-RD-specific pathogenic factors.
Among IgG4-specific class switch-related molecules,
the expression levels of Treg cytokines (IL-10 and
TGF-b) in LSGs of IgG4-RD were significantly higher
than in SS and the control, in agreement with previous
reports [4,5]. We assume that these cytokines might be
produced by Treg cells in LSGs of IgG4-RD. According
to this speculation, the mRNA expression level of
Foxp3, which is a master transcriptional factor for
Treg cells, was higher in LSGs of IgG4-RD than in the
control. We also showed that the expression of
GATA3 was significantly lower in LSGs of IgG4-RD
than in SS. It is reported that in salivary glands of SS,
Th2 cells were detected as well as Th1 cells, and could
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Figure 3 The mRNA expression levels of IgG4-nonspecific class switch-related molecules in PBMCs and LSGs. The displayed mRNA
expression levels are relative to the mRNA level of GAPDH, representing the internal control. Data are expressed as mean ± SD. *P < 0.05, Mann-
Whitney U-test. PBMCs, peripheral blood mononuclear cells; LSGs, labial salivary glands; HC, healthy control; SS, Sjögren syndrome; IgG4, IgG4-RD.
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contribute to activation of B cells through production
of IL-4 [17]. Therefore, the lower mRNA expression of
GATA3, a master transcriptional factor for Th2 cells,
in IgG4-RD than in SS might be upregulation in SS
but not downregulation in IgG4-RD. In SS, impaired
Treg response or imbalance between a Treg response
and a proinflammatory response might cause upregula-
tion of Th1 and Th2 response that contributed to the
pathophysiology of SS. Conversely, in IgG4-RD, upre-
gulation of the Treg response itself could contribute to
pathogenesis. Interestingly, it was previously reported
that IL-10 enhanced IgG4 production from IL-4-stimu-
lated PBMCs in vitro [9]. Therefore, in LSGs of IgG4-
RD, IL-10 might induce IgG4-specific class-switch
recombination, and TGF-b might cause tissue fibrosis
[5,11]. Thus, Treg cytokines (IL-10 and TGF-b) might
play important roles in IgG4-specific class-switch
recombination and fibrosis, which are characteristic
features of IgG4-RD.
Among IgG4-nonspecific class switch-related molecules,
the expression of AID was significantly higher in LSGs of
IgG4-RD than in SS and the control. The roles of IgG4-
nonspecific class switch-related molecules such as AID in
the pathogenesis of IgG4-RD have not been reported pre-
viously. The present study showed that the expression
level of AID was different in IgG4-RD than in SS and the
control. AID is essential for nonspecific immunoglobulin
class-switch recombination (from IgM to IgG1, IgG2,
IgG3, IgG4, IgA, and IgE) [12-14]; thus, upregulation of
AID could also contribute to upregulation of IgG4-specific
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Figure 4 The mRNA expression levels of IgG4-nonspecific class switch-related molecules in CD3-positive T cells and CD20-positive B
cells sorted from PBMCs. The displayed mRNA expression levels are relative to the mRNA level of GAPDH, representing the internal control.
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class-switch recombination along with IL-10 in LSGs of
IgG4-RD.
We showed that in SS, the population of CD20-positive
B cells in PBMCs was much more than IgG4-RD and the
control (statistically not significant). Therefore, CD40 and
CD154 mRNAs in PBMCs of SS were highly expressed
compared with that in IgG4-RD. These findings might be
due to systemic B-cell activation in SS patients instead of
local B-cell activation in IgG4-RD. Moreover, in CD3-
positive T cells and CD20-positive B cells sorted from
PBMCs, we found no IgG4-specific, -nonspecific, class
switch-related molecules with different expression levels
in IgG4-RD than in SS and controls.
These observations on the expression levels of AID and
Treg cytokines suggest that IgG4 class-switch recombina-
tion in IgG4-RD was upregulated mainly in the tissues of
the affected organs. However, the mechanism of upregula-
tion of Treg cytokines in IgG4-RD is unknown. Treg
response itself primarily regulates the immune response
and inflammation [17]; therefore, increased Treg cytokines
could be a nonspecific response to dampen the inflamma-
tion, which could increase the IgG4 class switch in the
tissues.
Conclusion
This study showed different expression levels of IgG4 class
switch-related molecules in LSGs than in PBMCs of IgG4-
RD. In LSGs of IgG4-RD, increased Treg cytokines (IL-10
and TGF-b) might play pathogenic roles in IgG4-specific
class-switch recombination and fibrosis. AID was also
increased in LSGs of IgG4-RD and could contribute to
upregulation of IgG4-specific class-switch recombination
along with IL-10 in LSGs. Thus, overexpression of IL-10,
TGF-b, and AID in LSGs might play important pathogenic
roles in IgG4-RD. IgG4 class-switch recombination
seemed to be mainly upregulated in affected organs.
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